Healthcare
The global DNA sequencing products market size reached US$ 6.9 Billion in 2023. As per the analysis by IMARC Group, the top companies in the global DNA sequencing products market are focusing on various technological advancements, such as the introduction of nanopore and single-molecule sequencing. Moreover, the increasing demand for DNA sequencing products to decipher the genetic information of organisms owing to rapid advancements in genomics research is favoring the market growth. In line with this, the growing demand for precision medicine to offer specific treatments or therapies is acting as another growth-inducing factor. Apart from this, researchers and instrument developers have produced an array of DNA sequencing technologies that offer faster sequencing with higher accuracy at lower costs, which, in turn, is providing an impetus to the market growth. Continual technological advancements in the sector, such as the introduction of Immensa Genomic Interpretation Software that helps researchers interpret the genome sequencing data for the purpose of pharmacogenomics and nutrigenomics, are facilitating the market growth. Furthermore, DNA sequencing has been widely adopted for clinical and diagnostic applications, such as identifying genetic mutations, diagnosing genetic diseases, and predicting disease risk, which is positively influencing the market growth. Additionally, key players are focusing on reducing sequencing costs and enhancing research and development (R&D) activities to offer cost-effective solutions, such as de novo sequencing, whole genome sequencing, and specific disease diagnosis, which is providing a considerable boost to the market growth. Besides this, the increasing demand for DNA sequencing in the in-vitro diagnostics market for point-of-care diagnostics is creating a positive outlook for the market. Other factors, including the widespread adoption of DNA sequencing in agriculture and livestock research for animal breeding, crop improvement, livestock management, and miniaturization of DNA sequencing products are anticipated to drive the market growth. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032.
Learn about opportunities, challenges, and trends in the global DNA sequencing products Market with IMARC’s market research report. Try a free sample today!
The global DNA sequencing products market has several major players including Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., and Beckman Coulter. More information about these companies has been provided below.
Establishment: |
1998 |
Headquarters: |
San Diego, California, United States |
Website: |
https://www.illumina.com/ |
Illumina Inc. is a leading biotechnology company that has emerged as a leader in genetic sequencing and genomic solutions, revolutionizing the field of life sciences and genomics research. The company's flagship sequencing systems, including the NovaSeq, HiSeq, and MiSeq platforms, are known for their high throughput, accuracy, and scalability, allowing researchers to generate vast amounts of DNA sequence data rapidly and cost-effectively. In addition, Illumina Inc. invests heavily in research and development (R&D) to continuously improve its sequencing platforms, sample preparation kits, and data analysis solutions. The company's sequencers are widely used in academic research institutions, pharmaceutical companies, clinical laboratories, and biotechnology companies around the world.
Establishment: |
1956 |
Headquarters: |
Waltham, Massachusetts, United States |
Website: |
https://www.thermofisher.com/in |
Thermo Fisher Scientific Inc. is a leading global provider of scientific research products, including a wide range of DNA sequencing products. It offers a comprehensive portfolio of DNA sequencing products encompassing various aspects of the sequencing workflow, from sample preparation to data analysis. These sequencing systems are known for their accuracy, scalability, and ease of use, enabling researchers to generate high-quality DNA sequence data for a wide range of applications, from whole-genome sequencing to targeted sequencing, RNA sequencing, and metagenomics.
Establishment: |
1896 |
Headquarters: |
Basel, Switzerland |
Website: |
https://www.roche.com/ |
F. Hoffmann-La Roche Ltd, commonly known as Roche, is a Swiss multinational healthcare company with a wide range of healthcare solutions, including innovative DNA sequencing products. The sequencing product portfolio includes a variety of cutting-edge platforms and solutions that cater to different research and clinical needs. F. Hoffmann-La Roche Ltd also encompasses a wide range of sample preparation kits, reagents, consumables, and software solutions that support the entire sequencing workflow. The products are designed to ensure accurate and reliable sample preparation, library construction, and sequencing, focusing on ease of use and reproducibility.
Establishment: |
2004 |
Headquarters: |
Menlo Park, California, United States |
Website: |
https://www.pacb.com/ |
Pacific Biosciences of California, Inc., is a leading biotechnology company specializing in developing and commercializing DNA sequencing technologies, focusing on long-read sequencing platforms that offer high accuracy and enable a wide range of applications in genomics research, clinical diagnostics, and agriculture. The company follows strict manufacturing processes and quality control standards to ensure the performance and accuracy of its platforms and consumables.
Establishment: |
1935 |
Headquarters: |
Brea, California, United States |
Website: |
https://www.beckmancoulter.com/ |
Beckman Coulter is a global biotechnology company specializing in developing and commercializing innovative solutions for life sciences research, diagnostics, and healthcare. It offers a DNA sequencing product portfolio that includes a range of instruments, consumables, and reagents that are designed to enable accurate and efficient DNA sequencing workflows. In addition, the company actively participates in collaborative research projects, scientific conferences, and industry events.
About Author:
Aditi Kumar Senior Content Writer at IMARC Services Private Limited Aditi is a content writer and editor at IMARC Services Private Limited with over two years of experience in market research, covering diverse sectors from information technology to healthcare, automotive, oil and gas, food and beverage, and electronics. She actively works on numerous predictive and exploratory research projects and has hands-on experience analyzing and writing about macro and micro markets. Besides writing, Aditi loves baking and reading novels. |
Phone: +1-631-791-1145
Phone: +91-120-433-0800
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
134 N 4th St. Brooklyn, NY 11249, USA
+1-631-791-1145
Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India
+91-120-433-0800
30 Churchill Place London E14 5EU, UK
+44-753-714-6104
© Copyright IMARC Services Private Limited 2024. All rights reserved. Terms & Conditions | Privacy Policy | SiteMap